BRISTOL-MYERS SQUIBB RECEIVES USE PATENT FOR "UNPATENTABLE" TAXOL: THREE-HOUR BREAST AND OVARIAN INFUSION SCHEDULE COVERED BY PATENT THAT EXPIRES IN 2012
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
